| Drug Name |
Mometasone furoate monohydrate |
| Drug ID |
BADD_D01492 |
| Description |
Mometasone furoate is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions[FDA Label][F4292,F4295]. It has a glucocorticoid receptor binding affinity 22 times stronger than [dexamethasone] and higher than many other corticosteroids as well[A176906]. Mometasone furoate is formulated as a dry powder inhaler, nasal spray, and ointment for its different indications[FDA Label][F4292,F4295]. |
| Indications and Usage |
The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
D07AC13; D07XC03; R01AD09; R03BA07 |
| DrugBank ID |
DB14512
|
| KEGG ID |
D03325
|
| MeSH ID |
D000068656
|
| PubChem ID |
9893453
|
| TTD Drug ID |
D03HYX
|
| NDC Product Code |
50909-5152; 64918-0331; 53104-7663; 58175-0551; 15308-2710; 22552-0021; 64918-1912; 63190-0320; 63190-0690 |
| Synonyms |
Mometasone Furoate | Furoate, Mometasone | Nasonex | Mometasone Furoate Monohydrate | Furoate Monohydrate, Mometasone | Monohydrate, Mometasone Furoate | Asmanex Twisthaler | Twisthaler, Asmanex | Asmanex | Rinelon | Elocon | Sch 32088 | Sch-32088 | Sch32088 | Mometasone |
